E07928_BALF supernant
Severe acute respiratory syndrome coronavirus 2
Total RNA from the BALF supernant of critical COVID-19 patients
collected_by
Mu Wang, National Key Laboratory of Immunity and Inflammation, Institute of Immunology, Naval Medical University
collection_date
2022-12-28
geo_loc_name
China:Shanghai
host
Homo sapiens
host_disease
COVID-19
isolate
Hostipal admission NO. E07928 Mechanical ventilation
isolation_source
The urban areas of Shanghai during the Omicron outbreak from the end of 2022 to the beginning of 2029. The First Affiliated Hospital of Naval Medical University. Patients in the Intensive care unit
antiviral_treatment_agent
Paxlovid
collection_device
Bronchoscope
collection_method
bronchoalveolar lavage (BAL)
date_of_prior_antiviral_treat
2022-12-27
exposure_event
respiratory air exposure transmission
geo_loc_exposure
China
host_age
61
host_anatomical_material
Bronchoalveolar lavage fluid
host_anatomical_part
Bronchoalveolar segment
host_body_product
Bronchoalveolar lavage fluid
host_disease_outcome
Death
host_health_state
Dermatomyositis
host_sex
female
host_subject_id
E07928
lat_lon
31.2304 N 121.4737 E
prior_sars_cov_2_antiviral_treat
no
prior_sars_cov_2_infection
no
prior_sars_cov_2_vaccination
yes - completed
purpose_of_sampling
Reasearch
purpose_of_sequencing
random sampling
sars_cov_2_diag_gene_name_1
ORF1ab (rep)
sars_cov_2_diag_gene_name_2
ORF1ab (rep)
sars_cov_2_diag_pcr_ct_value_1
27
sars_cov_2_diag_pcr_ct_value_2
24
sequenced_by
Shanghai biotechnology Co., Ltd. (Shanghai, China)
BioSampleModel
SARS-CoV-2: clinical or host-associated